These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Wang HJ, Yu CL, Kishi H, Motoki K, Mao ZB, Muraguchi A. Chin Med J (Engl); 2006 Aug 20; 119(16):1365-73. PubMed ID: 16934183 [Abstract] [Full Text] [Related]
10. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models. Nixon AJ, Grol MW, Lang HM, Ruan MZC, Stone A, Begum L, Chen Y, Dawson B, Gannon F, Plutizki S, Lee BHL, Guse K. Arthritis Rheumatol; 2018 Nov 20; 70(11):1757-1768. PubMed ID: 30044894 [Abstract] [Full Text] [Related]
11. Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders. Schulze-Tanzil G, Zreiqat H, Sabat R, Kohl B, Halder A, Müller RD, John T. Curr Gene Ther; 2009 Aug 20; 9(4):306-15. PubMed ID: 19534651 [Abstract] [Full Text] [Related]
15. Inhibition of cartilage degradation and suppression of PGE2 and MMPs expression by pomegranate fruit extract in a model of posttraumatic osteoarthritis. Akhtar N, Khan NM, Ashruf OS, Haqqi TM. Nutrition; 2017 Jan 20; 33():1-13. PubMed ID: 27908544 [Abstract] [Full Text] [Related]
16. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Abramson SB, Amin A. Rheumatology (Oxford); 2002 Sep 20; 41(9):972-80. PubMed ID: 12209029 [Abstract] [Full Text] [Related]
17. Activated human B cells induce inflammatory fibroblasts with cartilage-destructive properties and become functionally suppressed in return. Störch H, Zimmermann B, Resch B, Tykocinski LO, Moradi B, Horn P, Kaya Z, Blank N, Rehart S, Thomsen M, Lorenz HM, Neumann E, Tretter T. Ann Rheum Dis; 2016 May 20; 75(5):924-32. PubMed ID: 25985971 [Abstract] [Full Text] [Related]
19. The roles of catabolic factors in the development of osteoarthritis. Blasioli DJ, Kaplan DL. Tissue Eng Part B Rev; 2014 Aug 20; 20(4):355-63. PubMed ID: 24172137 [Abstract] [Full Text] [Related]
20. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB. Arthritis Res; 1999 Aug 20; 1(1):81-91. PubMed ID: 11056663 [Abstract] [Full Text] [Related] Page: [Next] [New Search]